EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC 4.0

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study

Hyun Ji Lee, Yuri Woo, Young Bok Lee, Ji Hye Lee, Jung Eun Kim, Ji Hyun Lee, Sang Hyun Cho

Acta Dermato-Venereologica · 12.02.2025 · 105 · adv40704

DOI: 10.2340/actadv.v105.40704 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 12.02.2025. Verfasst von Hyun Ji Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Antibodies, Monoclonal, Humanized, Immunosuppressive Agents, Patient Reported Outcome Measures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis is a chronic skin disease affecting quality of life, sleep, and mental health. Traditional evaluation methods focus on clinical assessments, but there is a growing need for tools that incorporate patient-reported outcomes (PROs). To evaluate the effectiveness of the Atopic Dermatitis Control Tool (ADCT) in assessing disease severity in patients with moderate to severe atopic dermatitis and to compare the efficacy of systemic immunosuppressants and dupilumab in patients with moderate to severe atopic dermatitis. A prospective, observational study was conducted across seven centres in Korea, involving 112 patients with moderate to severe atopic dermatitis. The ADCT, Eczema Area and Severity Index (EASI), and Dermatology Life Quality Index (DLQI) were used for assessing atopic dermatitis severity. In addition, the study assessed the effectiveness of immunosuppressants and dupilumab over the course of one year. The study found significant correlations between ADCT scores and other severity measures (EASI, DLQI). The correlation coefficients were 0.54 (p < 0.0001) for ADCT vs EASI and 0.83 (p < 0.0001) for ADCT vs DLQI. Furthermore, patients treated with dupilumab exhibited greater improvement compared with those on cyclosporine, as measured by the ADCT (adjusted OR [95% CI]); 6.98 [2.49, 19.58]). The ADCT effectively captures subjective aspects compared with the EASI and can be used practically and effectively in clinical settings of atopic dermatitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsPatient Reported Outcome MeasuresCyclosporineHumansProspective StudiesMaleFemaleAdultSeverity of Illness IndexTreatment OutcomeMiddle AgedQuality of LifeRepublic of KoreaYoung AdultTime FactorsAdolescentPredictive Value of TestsSurveys and Questionnaires

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsCyclosporine

Autor:innen und Institutionen

  • Department of Dermatology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Dermatology, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Dermatology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ejee@catholic.ac.kr.

Zitieren

APA

Lee, H. J., Woo, Y., Lee, Y. B., Lee, J. H., Kim, J. E., Lee, J. H., & Cho, S. H. (2025). Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study. Acta Dermato-Venereologica, 105, adv40704. https://doi.org/10.2340/actadv.v105.40704

Vancouver

Lee HJ, Woo Y, Lee YB, Lee JH, Kim JE, Lee JH, et al. Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study. Acta Dermato-Venereologica. 2025;105:adv40704. doi:10.2340/actadv.v105.40704

BibTeX
@article{Lee2025,
  author = {Lee, Hyun Ji and Woo, Yuri and Lee, Young Bok and Lee, Ji Hye and Kim, Jung Eun and Lee, Ji Hyun and Cho, Sang Hyun},
  title = {Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  volume = {105},
  pages = {adv40704},
  doi = {10.2340/actadv.v105.40704}
}
Kostenlos starten →